Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease

Pediatric Research

Volumn 57, Issue 3, 2005, Pages 445-452

  Alwayn, Ian P J ^a   Gura, Kathleen ^a   Nosé, Vânia ^a   Zausche, Blanca ^a   Javid, Patrick ^a   Garza, Jennifer ^a   Verbesey, Jennifer ^a   Voss, Stephan ^a   Ollero, Mario ^b   Andersson, Charlotte ^b   Bistrian, Bruce ^b   Folkman, Judah ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CARBOHYDRATE; LIPID EMULSION; OMEGA 3 FATTY ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; FATTY ACID ANALYSIS; FATTY LIVER; INFLAMMATION; LIPOGENESIS; LIVER; LIVER FUNCTION TEST; LIVER INJURY; LIVER PROTECTION; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARENTERAL NUTRITION; PRIORITY JOURNAL; SUPPLEMENTATION;

ANIMALS; DIET; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FATTY ACIDS; FATTY ACIDS, OMEGA-3; FATTY LIVER; HUMANS; LIVER; MICE; MICE, INBRED C57BL;

EID: 20044376106     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000153672.43030.75     Document Type: Article

References (64)

1. Angulo P 2002 Nonalcoholic fatty liver disease. N Engl J Med 346:1221-1231
2. Clark JM, Brancati FL, Diehl AM 2002 Nonalcoholic fatty liver disease. Gastroenterology 122:1649-1657
3. Clark JM, Diehl AM 2003 Defining nonalcoholic fatty liver disease: implications for epidemiologic studies. Gastroenterology 124:248-250
4. Teli MR, James OF, Burt AD, Bennett MK, Day CP 1995 The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 22:1714-1719
5. Clark JM, Brancati FL, Diehl AM 2003 The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98:960-967
6. Bellentani S, Saccoccio G, Masutti F, Croce LS, Brandi G, Sasso F, Cristanini G, Tiribelli C 2000 Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 132:112-117
7. Wanless IR, Lentz JS 1990 Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12:1106-1110
8. Ratziu V, Giral P, Charlotte F, Bruckert E, Thibault V, Theodorou I, Khalil L, Turpin G, Opolon P, Poynard T 2000 Liver fibrosis in overweight patients. Gastroenterology 118:1117-1123
9. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S 1998 The metabolically obese, normal-weight individual revisited. Diabetes 47:699-713
10. Clark JM, Diehl AM 2002 Hepatic steatosis and type 2 diabetes mellitus. Curr Diab Rep 2:210-215
11. Sahoo S, Hart J 2003 Histopathological features of L-asparaginase-induced liver disease. Semin Liver Dis 23:295-299
12. Kooby DA, Fong Y, Suriawinata A, Gonen M, Allen PJ, Klimstra DS, DeMatteo RP, D'Angelica M, Blumgart LH, Jarnagin WR 2003 Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 7:1034-1044
13. Sax HC, Talamini MA, Brackett K, Fischer JE 1986 Hepatic steatosis in total parenteral nutrition: failure of fatty infiltration to correlate with abnormal serum hepatic enzyme levels. Surgery 100:697-704
14. Sax HC, Bower RH 1988 Hepatic complications of total parenteral nutrition. JPEN J Parenter Enteral Nutr 12:615-618
15. Hughes CA, Talbot IC, Ducker DA, Harran MJ 1983 Total parenteral nutrition in infancy: effect on the liver and suggested pathogenesis. Gut 24:241-248
16. Benjamin DR 1981 Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition. A clinico-pathologic study. Am J Clin Pathol 76:276-283
17. Mullick FG, Moran CA, Ishak KG 1994 Total parenteral nutrition: a histopathologic analysis of the liver changes in 20 children. Mod Pathol 7:190-194
18. Levine A, Maayan A, Shamir R, Dinari G, Sulkes J, Sirotta L 1999 Parenteral nutrition-associated cholestasis in preterm neonates: evaluation of ursodeoxycholic acid treatment. J Pediatr Endocrinol Metab 12:549-553
19. Kaufman SS 2002 Prevention of parenteral nutrition-associated liver disease in children. Pediatr Transplant 6:37-42
20. Day CP, James OF 1998 Steatohepatitis: a tale of two "hits"? Gastroenterology 114:842-845
21. Day CP 2002 Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 16:663-678
22. Helms RA, Miller JL, Burckart GJ, Allen RG 1983 Clinical outcome as assessed by anthropometric parameters, albumin, and cellular immune function in high-risk infants receiving parenteral nutrition. J Pediatr Surg 18:564-569
23. Moss RL, Das JB, Raffensperger JG 1993 Total parenteral nutrition-associated cholestasis: clinical and histopathologic correlation. J Pediatr Surg 28:1270-1274; discussion 1274-1275
24. Moss RL, Haynes AL, Pastuszyn A, Glew RH 1999 Methionine infusion reproduces liver injury of parenteral nutrition cholestasis. Pediatr Res 45:664-668
25. Su KP, Huang SY, Chiu CC, Shen WW 2003 Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial. Eur Neuropsychopharmacol 13:267-271
26. Freeman MP 2000 Omega-3 fatty acids in psychiatry: a review. Ann Clin Psychiatry 12:159-165
27. Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP 2003 Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophr Res 62:195-204
28. Mata Lopez P, Ortega RM 2003 Omega-3 fatty acids in the prevention and control of cardiovascular disease. Eur J Clin Nutr 57:S22-S25
29. Leaf A, Kang JX, Xiao YF, Billman GE 2003 Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils. Circulation 107:2646-2652
30. Simopoulos AP 2002 Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr 21:495-505
31. De Vizia B, Raia V, Spano C, Pavlidis C, Coruzzo A, Alessio M 2003 Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis. JPEN J Parenter Enteral Nutr 27:52-57
32. Chen MF, Lee YT, Hsu HC, Yeh PC, Liau CS, Huang PC 1992 Effects of dietary supplementation with fish oil on prostanoid metabolism during acute coronary occlusion with or without reperfusion in diet-induced hypercholesterolemic rabbits. Int J Cardiol 36:297-304
33. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ 2003 NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol 284:L84-L89
34. Babcock TA, Novak T, Ong E, Jho DH, Helton WS, Espat NJ 2002 Modulation of lipopolysaccharide-stimulated macrophage tumor necrosis factor-alpha production by omega-3 fatty acid is associated with differential cyclooxygenase-2 protein expression and is independent of interleukin-10. J Surg Res 107:135-139
35. Mayer K, Merfels M, Muhly-Reinholz M, Gokorsch S, Rosseau S, Lohmeyer J, Schwarzer N, Krull M, Suttorp N, Grimminger F, Seeger W 2002 Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol 283:H811-H818
36. Mayer K, Meyer S, Reinholz-Muhly M, Maus U, Merfels M, Lohmeyer J, Grimminger F, Seeger W 2003 Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 171:4837-4843
37. Rallidis LS, Paschos G, Liakos GK, Velissaridou AH, Anastasiadis G, Zampelas A 2003 Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients. Atherosclerosis 167:237-242
38. Park Y, Harris WS 2003 Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance. J Lipid Res 44:455-463
39. Van Aerde JE, Duerksen DR, Gramlich L, Meddings JB, Chan G, Thomson AB, Clandinin MT 1999 Intravenous fish oil emulsion attenuates total parenteral nutrition-induced cholestasis in newborn piglets. Pediatr Res 45:202-208
40. Yeh SL, Chang KY, Huang PC, Chen WJ 1997 Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 13:32-36
41. Chen WJ, Yeh SL 2003 Effects of fish oil in parenteral nutrition. Nutrition 19:275-279
42. Sekiya M, Yahagi N, Matsuzaka T, Najima Y, Nakakuki M, Nagai R, Ishibashi S, Osuga J, Yamada N, Shimano H 2003 Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP-1 suppression. Hepatology 38:1529-1539
43. Araya J, Rodrigo R, Videla LA, Thielemann L, Orellana M, Pettinelli P, Poniachik J 2004 Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in non-alcoholic fatty liver disease patients. Clin Sci (Lond) 106:635-643
44. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C 2000 Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enterai Nutr 24:345-350
45. Alwayn JP, Javid PJ, Gura KM, Nose V, Ollero M, Puder M 2004 Do polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREPB-1 suppression or by correcting essential fatty acid deficiency? Hepatology 39:1176-1177; author reply 1177-1178
46. Alvarez JG, Touchstone JC 1992 Separation of acidic and neutral lipids by aminopropyl-bonded silica gel column chromatography. J Chromatogr 577:142-145
47. Yang H, Finaly R, Teitelbaum DH 2003 Alteration in epithelial permeability and ion transport in a mouse model of total parenteral nutrition. Crit Care Med 31:1118-1125
48. Ohta K, Omura K, Hirano K, Kanehira E, Ishikawa N, Kato Y, Kawakami K, Watanabe G 2003 The effects of an additive small amount of a low residual diet against total parenteral nutrition-induced gut mucosal barrier. Am J Surg 185:79-85
49. Reeves PG, Nielsen FH, Fahey GC Jr 1993 AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951
50. Keim NL, Mares-Perlman JA 1984 Development of hepatic steatosis and essential fatty acid deficiency in rats with hypercaloric, fat-free parenteral nutrition. J Nutr 114:1807-1815
51. Goheen SC, Larkin EC, Rao GA 1983 Severe fatty liver in rats fed a fat-free ethanol diet, and its prevention by small amounts of dietary arachidonate. Lipids 18:285-290
52. Allardyce DB 1982 Cholestasis caused by lipid emulsions. Surg Gynecol Obstet 154:641-647
53. Cavicchi M, Crenn P, Beau P, Degott C, Boutron MC, Messing B 1998 Severe liver complications associated with long-term parenteral nutrition are dependent on lipid parenteral input. Transplant Proc 30:2547
54. Cavicchi M, Beau P, Crenn P, Degott C, Messing B 2000 Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 132:525-532
55. Clayton PT, Whitfield P, Iyer K 1998 The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 14:158-164
56. Chen WJ, Yeh SL, Huang PC 1996 Effects of fat emulsions with different fatty acid composition on plasma and hepatic lipids in rats receiving total parenteral nutrition. Clin Nutr 15:24-28
57. Zaman N, Tam YK, Jewell LD, Coutts RT 1997 Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos 18:803-819
58. Fernandes G 1994 Dietary lipids and risk of autoimmune disease. Clin Immunol Immunopathol 72:193-197
59. Burdge GC, Finnegan YE, Minihane AM, Williams CM, Wootton SA 2003 Effect of altered dietary n-3 fatty acid intake upon plasma lipid fatty acid composition, conversion of [13C]alpha-linolenic acid to longer-chain fatty acids and partitioning towards beta-oxidation in older men. Br J Nutr 90:311-321
60. Neschen S, Moore I, Regittnig W, Yu CL, Wang Y, Pypaert M, Petersen KF, Shulman GI 2002 Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am J Physiol 282:E395-E401
61. Willumsen N, Hexeberg S, Skorve J, Lundquist M, Berge RK 1993 Docosahexaenoic acid shows no triglyceride-lowering effects but increases the peroxisomal fatty acid oxidation in liver of rats. J Lipid Res 34:13-22
62. Rustan AC, Nossen JO, Christiansen EN, Drevon CA 1988 Eicosapentaenoic acid reduces hepatic synthesis and secretion of triacylglycerol by decreasing the activity of acyl-coenzyme A:1,2-diacylglycerol acyltransferase. J Lipid Res 29:1417-1426
63. Nossen JO, Rustan AC, Gloppestad SH, Malbakken S, Drevon CA 1986 Eicosapentaenoic acid inhibits synthesis and secretion of triacylglycerols by cultured rat hepatocytes. Biochim Biophys Acta 879:56-65
64. Bellenger J, Bellenger S, Clement L, Mandard S, Diot C, Poisson JP, Narce M 2004 A new hypotensive polyunsaturated fatty acid dietary combination regulates oleic acid accumulation by suppression of stearoyl CoA desaturase 1 gene expression in the SHR model of genetic hypertension. FASEB J 18:773-775